Technical specifications
Indications
Indicated for the habitual and chronic constipation, softening of the faeces and facilitation of the defecation in patients with haemorrhoids, anal fissures, fistulas, and rectum/anal post-surgery.
Indicated for the treatment and prevention of the chronic portal systemic encephalopathy.
Composition
Per sachet of 15 ml:
Lactulose: 10 g
Galactose:< 1,5 g
Lactose: <1,0 g
Epilactose: <1,0 g
Tagatose: < 0,4 g
Water c.s
Each 5 ml of solution contains:
Lactulose: 3,33 g
Galactose: <0,50 g
Lactose: <0,33 g
Epilactose: <0,33 g
Tagatose: <0,13 g
Water c.s
Presentation
Lactulosa Lainco E.F.G 10 sachets single-dose (stick pack) 15 ml* - C.N. 659921.1: PVP 2,99 €, PVP IVA 3,11 €
Lactulosa Lainco E.F.G 50 sachets single-dose (stick pack) 15 ml - C.N. 659919.8: PVP 10,58 €, PVP IVA 11,01 €
Lactulosa Lainco E.F.G 200 ml* - C.N. 659922.8: PVP 3,69 €, PVP IVA 3,84 €
Lactulosa Lainco E.F.G 800 ml* - C.N. 659923.5: PVP 8,99 €, PVP IVA 9,35 €
Clinical packagings:
Lactulosa Lainco E.F.G 200 sachets single-dose (stick pack) - C.N. 602684.7
Lactulosa Lainco E.F.G 800 ml - C.N. 602685.4
Medication subject to medical prescription. Not included in the offer of the National Health System.
* Included in the offer of the National Health System for treatment and prevention of portosystemic hepatic encephalopathy.